MECHANISM OF RESISTANCE OF A VARIANT OF P388 LEUKEMIA TO L-(ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (ACIVICIN)

被引：0

作者：

JAYARAM, HN

ARDALAN, B

DEAS, M

JOHNSON, RK

机构：

[1] NCI,DIV CANC TREATMENT,MED CHEM & PHARMACOL LAB,BETHESDA,MD 20205

[2] SO CALIF COMPREHENS CANC CTR,LOS ANGELES,CA 90033

[3] SK&F LABS,ANTINEOPLAST PROGRAM,PHILADELPHIA,PA 19101

来源：

CANCER RESEARCH | 1985年 / 45卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：207 / 212

页数：6

共 37 条

[1] STUDIES ON THE MECHANISM OF RESISTANCE TO L-[ALPHA-S,5S]-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (ACIVICIN)
JAYARAM, HN
COONEY, DA
SWINIARSKI, JK
JOHNSON, RK
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 22 - 22
[2] BIOCHEMICAL-MECHANISMS FOR THE SCHEDULED SYNERGISM OF ACIVICIN, L-(S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID AND 5-FLUOROURACIL IN P388 LEUKEMIA
ARDALAN, B
CHANDRASEKARAN, B
STOLINSKY, D
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 270 - 270
[3] COLLATERAL SENSITIVITY TO N-(PHOSPHONACETYL)-L-ASPARTIC ACID IN A LINE OF P388 LEUKEMIA-CELLS SELECTED FOR RESISTANCE TO L-(ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (ACIVICIN)
ARDALAN, B
JAYARAM, HN
JOHNSON, RK
CANCER RESEARCH, 1983, 43 (04) : 1598 - 1601
[4] TOTAL SYNTHESIS OF ANTITUMOR AGENT AT-125, (ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID
BALDWIN, JE
CHA, JK
KRUSE, LI
TETRAHEDRON, 1985, 41 (22) : 5241 - 5260
[5] MECHANISM OF INACTIVATION OF GLUTAMINE AMIDOTRANSFERASES BY THE ANTI-TUMOR DRUG L-(ALPHA-S, 5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (AT-125)
TSO, JY
BOWER, SG
ZALKIN, H
JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (14) : 6734 - 6738
[6] BIOCHEMICAL-MECHANISMS FOR THE SCHEDULED SYNERGISM OF (ALPHA-S, 5S)-2 AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID AND 5-FLUOROURACIL IN P388 LEUKEMIA
ARDALAN, B
CHANDRASEKARAN, B
HRISHIKESHAVAN, HJ
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (01) : 44 - 48
[7] ENHANCED EFFECT OF AN L-GLUTAMINE ANTAGONIST, L-(ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID, BY ACINETOBACTER L-GLUTAMINASE-L-ASPARAGINASE
HOLCENBERG, JS
CANCER TREATMENT REPORTS, 1979, 63 (06): : 1109 - 1114
[8] L-[ALPHA-S, 5S]-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (NSC-163501) - NEW AMINO-ACID ANTIBIOTIC WITH PROPERTIES OF AN ANTAGONIST OF L-GLUTAMINE
JAYARAM, HN
COONEY, DA
RYAN, JA
NEIL, G
DION, RL
BONO, VH
CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (03): : 481 - 491
[9] TOTAL SYNTHESIS OF ANTI-TUMOR AGENT AT-125, (ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID
BALDWIN, JE
KRUSE, LI
CHA, JK
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1981, 103 (04) : 942 - 943
[10] INHIBITION OF CELL-CYCLE PROGRESSION OF HUMAN PANCREATIC-CARCINOMA CELLS-INVITRO BY L-(ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID, ACIVICIN (NSC-163501)
MECK, RA
CLUBB, KJ
ALLEN, LM
YUNIS, AA
CANCER RESEARCH, 1981, 41 (11) : 4547 - 4553

← 1 2 3 4 →